HSA/FSA support planned for public launch
Treatments/Weight loss/Tirzepatide
Blood sugar
TirzepatideA weekly dual-pathway injection for appetite and blood sugar.
Choose a plan
Quarterly
Monthly
$299/mo
$349
10% less than monthly
MALIBU10
10% off your first order at checkout
Get startedA licensed provider sets your dose after reviewing your intake. Nothing is prescribed or charged until they approve it.
No insurance required
100% online — no calls, no appointment
Dispensed by a US-licensed pharmacy
Cancel or change plan any time
Physician-guided
No insurance needed
Cancel anytime
Discreet shipping
Tirzepatide, explained
Tirzepatide is a dual GIP and GLP-1 receptor agonist — it imitates two gut hormones rather than one. Both are released when you eat and both tell the brain the meal is over.
Two pathwaysGIP and GLP-1 act on appetite by different routes, which is why it is often tried when one alone has not suited.
Slows digestionThe stomach empties more gradually, so a meal satisfies for longer.
Steadies blood sugarFewer spikes after eating, which flattens the crash that follows.
What to expect
WEEKS 1–4
Starting lowYou begin at the smallest dose. Appetite usually changes before anything else does.
WEEKS 5–12
Stepping upYour provider raises the dose on a set schedule, and only if you are tolerating the one before it.
ONGOING
Holding steadyYou settle at the dose that works. Check-ins continue and you can change plans or stop.
Questions about tirzepatide?
Zuma knows this treatment, who it suits, and who tends not to qualify. No account needed.
Is this right for me?
How is it different from semaglutide?
What are the side effects?
Ask something else
The Malibu Protocol standardWe stand behind every treatment. No grey market. No research-only.
Physician-led care

Treatments are prescribed by a licensed clinician based on your intake.

MD
Independent licensed U.S. pharmacies

Every prescription is dispensed by an independent licensed U.S. pharmacy.

USP
Compounded in the USA

Made to order at the dose your clinician prescribed.

FDA
Only what's clinically appropriate

We only offer treatments that are legitimately available to prescribe.

503A
Who it isn't forSay so in your intake if any of these apply.
Conditions we screen for
Tirzepatide carries a boxed warning for thyroid C-cell tumours in animal studies. Your provider screens for a personal or family history of medullary thyroid carcinoma and for MEN 2.
None of this rules you out on its own. A provider reads your intake, and if tirzepatide isn't the right fit they will say so.
Check if I qualify — 2 minutes
Browse other treatments
Questions, answered
Is compounded tirzepatide FDA-approved?
How is it different from semaglutide?
How is my dose decided?
What if it isn't right for me?
Can I pause or stop?
Do I need insurance?
Also in Weight lossAll weight loss →
Tirzepatide
Blood sugar
GIP/GLP-1 · weekly injection
From$349/mo
More
Metformin
Blood sugar
Longevity
Insulin sensitivity · daily oral
From$59/mo
More
Glutathione
Detox
Skin
Antioxidant · weekly
From$129/mo
More
View all treatments
Not sure which one?Not a problem. Answer a few questions online — no calls, no appointment. A licensed provider reads them and decides what fits. Nothing is prescribed or charged until they do.Get started
Or ask Zuma first
Compounded medications are not approved by the FDA. When prescribed, they are prepared and dispensed by an independent licensed U.S. pharmacy. This page is for information only and is not medical advice. Prescriptions are written at the discretion of a U.S.-licensed clinician after review of your intake.
Semaglutide · quarterly$212/mo
Get started